RNA, U1 small nuclear 74, pseudogeneGenealiases: []
Q-omics provides the consensus-scored RNU1-74P profile across patient tissues and cancer cell-line models. RNU1-74P expression is associated with patient survival in 10 of 34 cancer types, with the highest sampling consensus in OV. Among the 18 cancer types available for tumor–normal comparison, RNU1-74P is differentially expressed in 2, with the highest sampling consensus in BLCA. Additionally, RNU1-74P RNA expression shows 6,075 significant pathway-activity associations, with the highest sampling consensus in STAD. Together, these results highlight OV, BLCA, and STAD as cancer lineages where RNU1-74P shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for RNU1-74P — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes RNU1-74P survival associations across molecular data types. RNU1-74P RNA expression shows survival associations in the most cancer types (10). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible RNU1-74P RNA expression–survival associations across cancer types. High RNU1-74P expression shows unfavorable associations in OV, KICH, SKCM, DLBC, COAD and LIHC. The OV Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p = .002). Together, the overview and detailed table identify OV as the clearest survival context for RNU1-74P RNA expression.
This table summarizes RNU1-74P tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 2. The strongest signals are observed in BLCA for RNA.
This table ranks reproducible tumor–normal expression differences for RNU1-74P. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. RNU1-74P shows lower tumor expression in KIRP and higher tumor expression in BLCA. The BLCA box plot shows higher RNU1-74P RNA expression in tumor versus normal tissue (log2 FC = +0.106, t-test p = .037).
This table shows molecular features associated with RNU1-74P in patient tissues and cancer cell lines. In patient samples, RNU1-74P shows the broadest associations at the RNA and protein expression levels, with STAD recurring as the lineage with the largest associated feature set.
